-
1
-
-
0031768678
-
Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology
-
Falk PG, Hooper LV, Mittvedt T, Gordon JI: Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998, 62: 1157-1170.
-
(1998)
Microbiol Mol Biol Rev
, vol.62
, pp. 1157-1170
-
-
Falk, P.G.1
Hooper, L.V.2
Mittvedt, T.3
Gordon, J.I.4
-
2
-
-
0036885585
-
The host-microbe interface within the gut
-
Shanahan F: The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 2002, 16: 915-931.
-
(2002)
Best Pract Res Clin Gastroenterol
, vol.16
, pp. 915-931
-
-
Shanahan, F.1
-
3
-
-
33947119626
-
Gut microbiota: Mining for therapeutic potential
-
O'Hara AM,MShanahan F: Gut microbiota: mining for therapeutic potential. Clin Gastroenterol Hepatol 2007, 5: 274-284.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 274-284
-
-
O'Hara, A.M.1
Shanahan, F.2
-
4
-
-
0037425743
-
Gut flora in health and disease
-
Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 2003, 361: 512-519.
-
(2003)
Lancet
, vol.361
, pp. 512-519
-
-
Guarner, F.1
Malagelada, J.R.2
-
5
-
-
10744233159
-
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis
-
Rachmilewitz D, Katakura K, Karmeli F, et al.: Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126: 520-528.
-
(2004)
Gastroenterology
, vol.126
, pp. 520-528
-
-
Rachmilewitz, D.1
Katakura, K.2
Karmeli, F.3
-
6
-
-
0037951267
-
Probiotics: A perspective on problems and pitfalls
-
ShanahAn F: Probiotics: a perspective on problems and pitfalls. Scand J Gastroenterol 2003, 38(suppl): 34-36.
-
(2003)
Scand J Gastroenterol
, vol.38
, Issue.SUPPL.
, pp. 34-36
-
-
Shanahan, F.1
-
8
-
-
33750016634
-
Clinical efficacy of probiotics: Review of the evidence with focus on children
-
NASPGHAN Nutrition Report Committee, Michail S, Sylvester F, et al.:
-
NASPGHAN Nutrition Report Committee, Michail S, Sylvester F, et al.: Clinical efficacy of probiotics: Review of the evidence with focus on children. J Pediatr Gastroenterol Nutr 2006, 43: 550-557.
-
(2006)
J Pediatr Gastroenterol Nutr
, vol.43
, pp. 550-557
-
-
-
9
-
-
43649100298
-
Bacterial flora in irritable bowel syndrome: Role in pathophysiology, implications for management
-
Quigley EM: Bacterial flora in irritablR bowel syndrome: role in pathophysiology, implications for management. J Dig Dis 2007, 8: 2-7.
-
(2007)
J Dig Dis
, vol.8
, pp. 2-7
-
-
Quigley, E.M.1
-
10
-
-
34547477105
-
Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome
-
Thabane M, Kottachchi DT, Marshall JK: Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26: 535-544.
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 535-544
-
-
Thabane, M.1
Kottachchi, D.T.2
Marshall, J.K.3
-
11
-
-
34147130268
-
Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen
-
Marshall JK, Thabane M, Borgaonkar MR, James C: Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007, 5: 457-460.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 457-460
-
-
Marshall, J.K.1
Thabane, M.2
Borgaonkar, M.R.3
James, C.4
-
12
-
-
0033056598
-
The role of psychological and biological factors in post-infective gut dysfunction
-
Gwee K-A, Leong Y-L, Graham C, et al.: The role of psychological and biological factors in post-infective gut dysfunction. Gut 1999, 44: 400-406.
-
(1999)
Gut
, vol.44
, pp. 400-406
-
-
Gwee, K.-A.1
Leong, Y.-L.2
Graham, C.3
-
13
-
-
0345059404
-
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS
-
Dunlop SP, Jenkins D, Neal KR, Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003, 125: 1651-1659.
-
(2003)
Gastroenterology
, vol.125
, pp. 1651-1659
-
-
Dunlop, S.P.1
Jenkins, D.2
Neal, K.R.3
Spiller, R.C.4
-
14
-
-
0033665517
-
Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
-
Spiller RC, Jenkins D, Thornley JP, et al.: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47: 804-811.
-
(2000)
Gut
, vol.47
, pp. 804-811
-
-
Spiller, R.C.1
Jenkins, D.2
Thornley, J.P.3
-
15
-
-
0037378888
-
Increased rectal mucosal expression of interleukin 1 beta in recently acquired post-infectious irritable bowel syndrome
-
Gwee K-A, Collins SM, Read NW, et al.: Increased rectal mucosal expression of interleukin 1 beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003, 52: 523-526.
-
(2003)
Gut
, vol.52
, pp. 523-526
-
-
Gwee, K.-A.1
Collins, S.M.2
Read, N.W.3
-
16
-
-
35348846734
-
Bacteria: A new player in gastrointestinal motility disorders-infections, bacterial overgrowth and probiotics
-
QuigAey EM: Bacteria: a new player in gastrointestinal motility disorders-infections, bacterial overgrowth and probiotics. Gastroenterol Clin N Am 2007, 36: 735-748.
-
(2007)
Gastroenterol Clin N Am
, vol.36
, pp. 735-748
-
-
Quigley, E.M.1
-
17
-
-
0036083346
-
Activation of the mucosal immune system in irritable bowel syndrome
-
Chadwick V, Chen W, Shu D, et al.: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122: 1778-1783.
-
(2002)
Gastroenterology
, vol.122
, pp. 1778-1783
-
-
Chadwick, V.1
Chen, W.2
Shu, D.3
-
18
-
-
33846193703
-
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome
-
Barbara G, Wang B, Stanghellini V, et al.: Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132: 26-37.
-
(2007)
Gastroenterology
, vol.132
, pp. 26-37
-
-
Barbara, G.1
Wang, B.2
Stanghellini, V.3
-
19
-
-
33847342529
-
Role for protease activity in visceral pain in irritable bowel syndrome
-
Cenac N, Andrews CN, Holzhausen M, et al.: Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007, 117: 636-647.
-
(2007)
J Clin Invest
, vol.117
, pp. 636-647
-
-
Cenac, N.1
Andrews, C.N.2
Holzhausen, M.3
-
20
-
-
15744374565
-
A randomized, placebo-controlled, double-blind comparison of the probiotic bacteria lactobacillus and bifidobacterium in irritable bowel syndrome (IBS): Symptom responses and relationship to cytokine profiles
-
O'Mahony L, McCarthy J, Kelly P, et al.: A randomized, placebo-controlled, double-blind comparison of the probiotic bacteria lactobacillus and bifidobacterium in irritable bowel syndrome (IBS): symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128: 541-551.
-
(2005)
Gastroenterology
, vol.128
, pp. 541-551
-
-
O'Mahony, L.1
McCarthy, J.2
Kelly, P.3
-
21
-
-
33947324517
-
Immune activation in patients with irritable bowel syndrome
-
Liebregts T, Adam B, Bredack C, et al.: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132: 913-920.
-
(2007)
Gastroenterology
, vol.132
, pp. 913-920
-
-
Liebregts, T.1
Adam, B.2
Bredack, C.3
-
22
-
-
32044459306
-
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker?
-
Dinan TG, Quigley EM, Ahmed SM, et al.: Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology 2006, 130: 304-311.
-
(2006)
Gastroenterology
, vol.130
, pp. 304-311
-
-
Dinan, T.G.1
Quigley, E.M.2
Ahmed, S.M.3
-
23
-
-
34447104397
-
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects
-
Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al.: The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133: 24-33.
-
(2007)
Gastroenterology
, vol.133
, pp. 24-33
-
-
Kassinen, A.1
Krogius-Kurikka, L.2
Mäkivuokko, H.3
-
24
-
-
34447106488
-
Irritable bowel syndrome: Shifting the focus toward the gut microbiota
-
Shanahan F: IrritablS bowel syndrome: shifting the focus toward the gut microbiota. Gastroenterology 2007, 133: 340-342.
-
(2007)
Gastroenterology
, vol.133
, pp. 340-342
-
-
Shanahan, F.1
-
25
-
-
34748841667
-
A 51-year-old with IBS. Test or treat for bacterial overgrowth?
-
Quigley EMM: A 51-year-old with IBS. Test or treat for bacterial overgrowth? Clin Gastroenterol Hepatol 2007, 5: 1140-1143.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 1140-1143
-
-
Quigley, E.M.M.1
-
26
-
-
34249790127
-
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
-
Posserud I, Stotzer PO, Bjornsson E, et al.: Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007, 56: 802-808.
-
(2007)
Gut
, vol.56
, pp. 802-808
-
-
Posserud, I.1
Stotzer, P.O.2
Bjornsson, E.3
-
27
-
-
41849111638
-
Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls
-
Bratten JR, Spanier J, Jones MP: Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008, 103: 958-963.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 958-963
-
-
Bratten, J.R.1
Spanier, J.2
Jones, M.P.3
-
28
-
-
33846926968
-
Probiotics in irritable bowel syndrome: A rationale for their use and an assessment of the evidence to date
-
Quigley EMM, Flourie B: ProbioticsAin irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 2007, 19: 166-172.
-
(2007)
Neurogastroenterol Motil
, vol.19
, pp. 166-172
-
-
Quigley, E.M.M.1
Flourie, B.2
-
29
-
-
0034767063
-
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
-
Niedzielin K, Kordecki H, Birkenfeld B: A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001, 13: 1143-1147.
-
(2001)
Eur J Gastroenterol Hepatol
, vol.13
, pp. 1143-1147
-
-
Niedzielin, K.1
Kordecki, H.2
Birkenfeld, B.3
-
30
-
-
0037392231
-
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
-
Kim HJ, Camilleri M, McKinzie S, et al.: A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003, 17: 895-904.
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 895-904
-
-
Kim, H.J.1
Camilleri, M.2
McKinzie, S.3
-
31
-
-
25844477007
-
A randomized controlled trial of probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating
-
Kim HJ, Vazquez Roque MI, Camilleri M, et al.: A randomized controlled trial of probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005, 17: 687-696.
-
(2005)
Neurogastroenterol Motil
, vol.17
, pp. 687-696
-
-
Kim, H.J.1
Vazquez Roque, M.I.2
Camilleri, M.3
-
32
-
-
24344472329
-
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention
-
Kajander K, Hatakka K, Poussa T, et al.: A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention. Aliment Pharmacol Ther 2005, 22: 387-394.
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 387-394
-
-
Kajander, K.1
Hatakka, K.2
Poussa, T.3
-
33
-
-
50949100435
-
Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome
-
Feb 15 (Epub ahead of print)
-
Sinn DH, Song JH, Kim HJ, et al.: Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 2008 Feb 15 (Epub ahead of print).
-
(2008)
Dig Dis Sci
-
-
Sinn, D.H.1
Song, J.H.2
Kim, H.J.3
-
34
-
-
34447298145
-
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial
-
Guyonnet D, Chassany O, Ducrotte P, et al.: Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007, 26: 475-486.
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 475-486
-
-
Guyonnet, D.1
Chassany, O.2
Ducrotte, P.3
-
35
-
-
33745569311
-
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
-
Whorwell PJ, Altinger L, Morel J, et al.: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006, 101: 1581-1590.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 1581-1590
-
-
Whorwell, P.J.1
Altinger, L.2
Morel, J.3
-
36
-
-
36749082433
-
Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota
-
Kajander K, Myllyluoma E, Rajilic-Stojanovic M, et al.: Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008, 27: 48-57.
-
(2008)
Aliment Pharmacol Ther
, vol.27
, pp. 48-57
-
-
Kajander, K.1
Myllyluoma, E.2
Rajilic-Stojanovic, M.3
-
37
-
-
34447325957
-
Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome
-
Kajander K, Krogius-Kurikka L, Rinttilä T, et al.: Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26: 463-473.
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 463-473
-
-
Kajander, K.1
Krogius-Kurikka, L.2
Rinttilä, T.3
-
38
-
-
34547580948
-
Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: An open-label, partially controlled, 1-year extension of a previously published controlled clinical trial/
-
Bittner AC, Croffut RM, Stranahan MC, Yokelson TN: Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: An open-label, partially controlled, 1-year extension of a previously published controlled clinical trial. Clin Ther 2007, 29: 1153-1160.
-
(2007)
Clin Ther
, vol.29
, pp. 1153-1160
-
-
Bittner, A.C.1
Croffut, R.M.2
Stranahan, M.C.3
Yokelson, T.N.4
-
39
-
-
30944444119
-
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
-
Verdu EF, Bercik P, Verma-Gandhu M, et al.: Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006, 55: 182-190.
-
(2006)
Gut
, vol.55
, pp. 182-190
-
-
Verdu, E.F.1
Bercik, P.2
Verma-Gandhu, M.3
-
40
-
-
33846103017
-
Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity
-
Bueno L, de Ponti F, Fried M, et al.: Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil 2007, 19(1 Suppl): 89-119.
-
(2007)
Neurogastroenterol Motil
, vol.19
, Issue.1 SUPPL.
, pp. 89-119
-
-
Bueno, L.1
de Ponti, F.2
Fried, M.3
-
41
-
-
33846100339
-
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
-
Rousseaux C, Thuru X, Gelot A, et al.: Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Med 2007, 13: 35-37.
-
(2007)
Nature Med
, vol.13
, pp. 35-37
-
-
Rousseaux, C.1
Thuru, X.2
Gelot, A.3
-
42
-
-
34547111846
-
Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation
-
Gareau MG, Jury J, MacQueen G, et al.: Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007, 56: 1522-1528.
-
(2007)
Gut
, vol.56
, pp. 1522-1528
-
-
Gareau, M.G.1
Jury, J.2
MacQueen, G.3
-
43
-
-
44949093373
-
The d-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model
-
Feb 25 (Epub ahead of print)
-
Duncker SC, Wang L, Hols P, Bienenstock J: The d-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model. Neurogastroenterol Motil 2008 Feb 25 (Epub ahead of print).
-
(2008)
Neurogastroenterol Motil
-
-
Duncker, S.C.1
Wang, L.2
Hols, P.3
Bienenstock, J.4
-
44
-
-
41549131731
-
Effectiveness of probiotics in the treatment of irritable bowel syndrome
-
Wilhelm SM, Brubaker CM, Varcak EA, Kale-Pradhan PB: Effectiveness of probiotics in the treatment of irritable bowel syndrome. Pharmacotherapy 2008, 28: 496-505.
-
(2008)
Pharmacotherapy
, vol.28
, pp. 496-505
-
-
Wilhelm, S.M.1
Brubaker, C.M.2
Varcak, E.A.3
Kale-Pradhan, P.B.4
-
46
-
-
0035050218
-
Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhea
-
Urbancsek H, Kazar T, Mezes I, et al.: Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhea. Eur J Gastroenterol Hepatol 2003, 13: 391-396.
-
(2003)
Eur J Gastroenterol Hepatol
, vol.13
, pp. 391-396
-
-
Urbancsek, H.1
Kazar, T.2
Mezes, I.3
-
47
-
-
33947521593
-
Use of probiotics for prevention of radiation-induced diarrhea
-
Delia P, Sansotta G, Donato V, et al.: Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007, 13: 912-915.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 912-915
-
-
Delia, P.1
Sansotta, G.2
Donato, V.3
-
48
-
-
33846865120
-
Meta-analysis of probiotics for the prevention of traveler's diarrhea
-
McFarland LV: Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007, 5: 97-105.
-
(2007)
Travel Med Infect Dis
, vol.5
, pp. 97-105
-
-
McFarland, L.V.1
-
49
-
-
33846287913
-
Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children
-
Szajewska H, Skorka A, Dylag M: Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007, 25: 257-264.
-
(2007)
Aliment Pharmacol Ther
, vol.25
, pp. 257-264
-
-
Szajewska, H.1
Skorka, A.2
Dylag, M.3
-
50
-
-
0037042674
-
Probiotics in prevention of antibiotic associated diarrhea: Meta-analysis
-
D'souza AL, Rajkumar CH, Cooke J, et al.: Probiotics in prevention of antibiotic associated diarrhea: Meta-analysis. BMJ 2002, 324: 1361-1366.
-
(2002)
BMJ
, vol.324
, pp. 1361-1366
-
-
D'souza, A.L.1
Rajkumar, C.H.2
Cooke, J.3
-
51
-
-
0036588144
-
Antibiotic associated diarrhea: A controlled study comparing plain antibiotic with those containing protected lactobacilli
-
Ahuja MC, Khamar B: AntibiAtic associated diarrhea: a controlled study comparing plain antibiotic with those containing protected lactobacilli. J Indian Med Assoc 2002, 100: 334-335.
-
(2002)
J Indian Med Assoc
, vol.100
, pp. 334-335
-
-
Ahuja, M.C.1
Khamar, B.2
-
52
-
-
33646713927
-
Efficacy of probiotics in prevention of acute diarrhoea: A meta-analysis of masked, randomised, placebo-controlled trials
-
Sazawal S, Hiremath G, Dhingra U, et al.: Efficacy of probiotics in prevention of acute diarrhoea: A meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006, 6: 374-382.
-
(2006)
Lancet Infect Dis
, vol.6
, pp. 374-382
-
-
Sazawal, S.1
Hiremath, G.2
Dhingra, U.3
-
53
-
-
33947169259
-
Probiotics and prebiotics: Effects on diarrhea
-
de Vrese M, Marteau PE: Probiotics and prebiotics: effects on diarrhea. J Nutr 2007, 137(3 Suppl 2): 803S-811S.
-
(2007)
J Nutr
, vol.137
, Issue.3 SUPPL. 2
-
-
de Vrese, M.1
Marteau, P.R.2
-
54
-
-
0346777280
-
Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation
-
Koebnick C, Wagner I, Leitzmann P, et al.: Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003, 17: 655-659.
-
(2003)
Can J Gastroenterol
, vol.17
, pp. 655-659
-
-
Koebnick, C.1
Wagner, I.2
Leitzmann, P.3
-
55
-
-
34047138836
-
Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight)
-
Amenta M, Cascio MT, Di Fiore P, Venturini I: Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight). Acta Biomed 2006, 77: 157-162.
-
(2006)
Acta Biomed
, vol.77
, pp. 157-162
-
-
Amenta, M.1
Cascio, M.T.2
Di Fiore, P.3
Venturini, I.4
-
56
-
-
14844303566
-
Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: A double-blind, placebo-controlled randomized trial
-
Banaszkiewicz A, Szajewska H: Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: A double-blind, placebo-controlled randomized trial. J Pediatr 2005, 146: 364-369.
-
(2005)
J Pediatr
, vol.146
, pp. 364-369
-
-
Banaszkiewicz, A.1
Szajewska, H.2
-
57
-
-
0035995860
-
Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly
-
Ouwehand AC, Lagstrom H, Suomalainen T, Salminen S: Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 2002, 46: 159-162.
-
(2002)
Ann Nutr Metab
, vol.46
, pp. 159-162
-
-
Ouwehand, A.C.1
Lagstrom, H.2
Suomalainen, T.3
Salminen, S.4
-
58
-
-
3042511702
-
Bacteriotherapy using fecal flora: Toying with human motions
-
Borody TJ, Warren EF, Leis SM, et al.: Bacteriotherapy using fecal flora: Toying with human motions. J Clin Gastroenterol 2004, 38: 475-483.
-
(2004)
J Clin Gastroenterol
, vol.38
, pp. 475-483
-
-
Borody, T.J.1
Warren, E.F.2
Leis, S.M.3
-
59
-
-
25444502912
-
Review article: Bifidobacteria as probiotic agents - Physiological effects and clinical benefits
-
Picard C, Fioramonti J, Francois A, et al.: Review article: bifidobacteria as probiotic agents-physiological effects and clinical benefits. Aliment Pharmacol Ther 2005, 22: 495-512.
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 495-512
-
-
Picard, C.1
Fioramonti, J.2
Francois, A.3
-
60
-
-
33644878279
-
Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation
-
Khalif IL, Konovitch EA, Maximova ID, Quigley EMM: Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005, 37: 838-849.
-
(2005)
Dig Liver Dis
, vol.37
, pp. 838-849
-
-
Khalif, I.L.1
Konovitch, E.A.2
Maximova, I.D.3
Quigley, E.M.M.4
-
61
-
-
33644910165
-
Germs, gas and the gut; the evolving role of the enteric flora in IBS
-
Quigley EM: Germs, gas and the gut; the evolving role of the enteric flora in IBS. Am J Gastroenterol 2006, 101: 334-335.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 334-335
-
-
Quigley, E.M.1
-
62
-
-
33846946465
-
Efficacy of probiotics and nutrients in functional gastrointestinal disorders: A preliminary clinical trial
-
Kim L, Hilli L, Orlowski J, et al.: Efficacy of probiotics and nutrients in functional gastrointestinal disorders: A preliminary clinical trial. Dig Dis Sci 2006, 51: 2134-2144.
-
(2006)
Dig Dis Sci
, vol.51
, pp. 2134-2144
-
-
Kim, L.1
Hilli, L.2
Orlowski, J.3
-
63
-
-
29244491643
-
Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication
-
Duman DG, Bor S, Ozütemiz O, et al.: Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. Eur J Gastroenterol Hepatol 2005, 17: 1357-1361.
-
(2005)
Eur J Gastroenterol Hepatol
, vol.17
, pp. 1357-1361
-
-
Duman, D.G.1
Bor, S.2
Ozütemiz, O.3
-
64
-
-
34547569295
-
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study
-
Cindoruk M, Erkan G, Karakan T, et al.: Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study. Helicobacter 2007, 12: 309-316.
-
(2007)
Helicobacter
, vol.12
, pp. 309-316
-
-
Cindoruk, M.1
Erkan, G.2
Karakan, T.3
|